400-921-8278
| Catalog_no | ADMC0949 |
| Product_name | AZD-3759 |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 880.00/1660.00/2660.00 |
| Specificity | Target: EGFR . Fields: AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Dilution | IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Purification | >98% |
| Concentration | 靶点：EGFR;IC50： 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | AZD-3759,AZD 3759,,AZD3759 |
| Observed_band | 459.14 |
| Notes | AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
